Literature DB >> 9449879

Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2.

S Brown, C Bantar, H K Young, S G Amyes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449879     DOI: 10.1016/S0140-6736(05)78210-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

Authors:  H M Donald; W Scaife; S G Amyes; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  The rise in bacterial resistance is partly because there have been no new classes of antibiotics since the 1960s.

Authors:  S G Amyes
Journal:  BMJ       Date:  2000-01-22

3.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.

Authors:  Delphine Girlich; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

5.  Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii.

Authors:  Claire Héritier; Laurent Poirel; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Acinetobacter baumannii at a tertiary-care teaching hospital in Jerusalem, Israel.

Authors:  A Simhon; G Rahav; G Shazberg; C Block; H Bercovier; M Shapiro
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Pseudo-outbreak of imipenem-resistant Acinetobacter baumannii resulting from false susceptibility testing by a rapid automated system.

Authors:  A Tsakris; A Pantazi; S Pournaras; A Maniatis; A Polyzou; D Sofianou
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.

Authors:  G Bou; G Cerveró; M A Domínguez; C Quereda; J Martínez-Beltrán
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

9.  IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998.

Authors:  Y W Chu; M Afzal-Shah; E T Houang; M I Palepou; D J Lyon; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

10.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.